A history of cancer was associated with a significantly higher average 10-year probability of cardiovascular disease compared to non-cancer controls (19.1% vs. 13.3%, p<0.001).
Cross-Sectional (n=6,421)
Do cancer survivors have a higher 10-year probability of cardiovascular disease based on the Framingham risk score compared to non-cancer controls?
Cancer survivors have a higher 10-year probability of cardiovascular disease compared to the general population, highlighting the need for targeted CVD prevention programs in this population.
Absolute Event Rate: 19.1% vs 13.3%
p-value: p=<0.001
BACKGROUND: Cardiovascular disease is an important cause of morbidity and mortality in cancer survivors. The aim of this study was to investigate the modifiable cardiovascular disease risk factors and 10-year probability of the disease based on the Framingham risk score in cancer survivors, compared with the general population. METHODS: A total of 1,225 cancer survivors and 5,196 non-cancer controls who participated in the 2007-2013 Korea National Health and Nutrition Examination Surveys were enrolled. We assessed modifiable cardiovascular disease risk factors including smoking, body mass index, physical inactivity, high blood pressure, high cholesterol, and elevated blood glucose level. The 10-year probability of cardiovascular disease was determined by applying the Framingham cardiovascular disease risk equation among cancer survivors and non-cancer controls, ranging from 30 to 74 years old who had no overt cardiovascular diseases. RESULTS: The proportion of subjects who had higher fasting glucose levels, hemoglobin A1c levels, systolic blood pressure, and low density lipoprotein cholesterol levels, and those who had lower high density lipoprotein cholesterol levels was significantly higher in the cancer survivors than in the non-cancer controls. The average 10-year probability of cardiovascular disease among the cancer survivors was higher than that in the non-cancer controls in both men and women. The average 10-year probability of cardiovascular disease in relation to the cancer type was significantly higher in patients with hepatic, colon, lung, breast, and gastric cancer. CONCLUSION: Cancer survivors have a higher cardiovascular disease risk and 10-year probability of cardiovascular disease than non-cancer controls. Control of cardiovascular disease risk factors and implementation of a well-defined cardiovascular disease prevention program are needed for treating cancer survivors.
So et al. (Fri,) conducted a cross-sectional in Cancer Survivorship (n=6,421). History of cancer vs. Non-cancer controls was evaluated on 10-year probability of cardiovascular disease (Framingham risk score) (p=<0.001). A history of cancer was associated with a significantly higher average 10-year probability of cardiovascular disease compared to non-cancer controls (19.1% vs. 13.3%, p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: